Evommune (EVMN) Other Non Operating Income (2024 - 2026)

Evommune (EVMN) has reported Other Non Operating Income for 3 consecutive years, with $2.3 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Other Non Operating Income rose 380.0% year-over-year to $2.3 million; the TTM figure through Mar 2026 stood at $13.0 million (changed N/A YoY), while the FY2025 annual figure was $12.2 million, up 280.69% from the prior year.
• Other Non Operating Income declined to $2.3 million in Q1 2026 per EVMN's latest filing, from $9.4 million in the prior quarter.
• Across five years, Other Non Operating Income topped out at $9.4 million in Q4 2025 and bottomed at $475000.0 in Q1 2025.
• Historically, Other Non Operating Income has averaged $2.4 million across 3 years, with a median of $790500.0 in 2024.
• On a YoY basis, Other Non Operating Income climbed as much as 1195.33% in 2025 and fell as far as 41.93% in 2025.
• Evommune's Other Non Operating Income stood at $728000.0 in 2024, then surged by 1195.33% to $9.4 million in 2025, then slumped by 75.82% to $2.3 million in 2026.
• Business Quant data shows EVMN's Other Non Operating Income at $2.3 million in Q1 2026, $9.4 million in Q4 2025, and $853000.0 in Q3 2025.